Logo image
Back
Epidemiology and management of massive, sub-massive, and non-massive pediatric pulmonary embolism: a systematic reviews
Journal article   Open access   Peer reviewed

Epidemiology and management of massive, sub-massive, and non-massive pediatric pulmonary embolism: a systematic reviews

Mohammed Alsabri, Dina Essam Abo-Elnour, Mohammed Ayyad, Mahmoud Shaaban Abdelgalil, Basel F Alqeeq and Muhammad Azan Shahid
BMC pediatrics, v 25(1), 330
26 Apr 2025
DOI: https://doi.org/10.1186/s12887-025-05472-4
PMID: 40287637
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1186/s12887-025-05472-4View
Published, Version of Record (VoR) Open

Abstract

Adolescent Anticoagulants - therapeutic use Child Computed Tomography Angiography Female Humans Pulmonary Embolism - diagnosis Pulmonary Embolism - epidemiology Pulmonary Embolism - therapy Risk Factors Severity of Illness Index Thrombolytic Therapy
To evaluate the current evidence on the diagnosis, management, and outcomes of pediatric pulmonary embolism (PE) across varying severity classifications, including massive, submassive, and non-massive presentations. A systematic review was conducted following PRISMA guidelines. Searches were performed in PubMed, Scopus, Web of Science, and Cochrane databases up to February 17, 2024. Eligible studies included pediatric and adolescent patients (≤ 21 years) with confirmed PE diagnoses. Risk of bias was assessed using the NIH tool. Six studies involving 258 pediatric patients with massive, submassive, or non-massive PE were included. Most patients were adolescents, with a mean age of 14.1 years and a predominance of females (62-66%). Risk factors included obesity, oral contraceptive use, thrombophilia, and autoimmune conditions. Computed tomography pulmonary angiography (CTPA) was the most frequently used diagnostic modality, showing varied lobar, segmental, and subsegmental involvement. Management strategies ranged from anticoagulation to catheter-directed thrombolysis and surgical thrombectomy. Outcomes varied by severity, with massive PE cases showing higher mortality and complications compared to submassive and non-massive cases. Pediatric PE requires tailored risk stratification and management strategies to optimize outcomes. Delays in diagnosis and severe disease presentations contribute to higher morbidity and mortality. Future research should focus on standardized severity classifications, novel diagnostic modalities, and comparative assessments of therapeutic interventions to enhance outcomes in this population.

Metrics

1 Record Views
3 citations in Web of Science

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Pediatrics
Logo image